Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal Men
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Azurity Pharmaceuticals
- Study ID
- NCT07328542
- Phase
- PHASE4
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Hypogonadism, Male
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Testosterone Cypionate Injection 200 mg/mL — DRUGParticipants will receive Testosterone Cypionate Injection 200 mg/mL at established dose during the titration and treatment periods every two weeks (± 2 days) as a deep intramuscular injection in the gluteal muscle for 14-week study duration.
Study Details
A Phase 4, multi-center, open-label, single-arm 24-hour Ambulatory Blood Pressure Monitoring (ABPM) study of Testosterone Cypionate Injection in Hypogonadal Men to assess change in 24-hour ambulatory blood pressure from Baseline to End of Treatment
Key Dates
- Start date
- Feb 28, 2026
- Status verified
- Jan 2026
- Primary completion
- Jun 30, 2027
- Completion
- Aug 31, 2027
Study Design
- Enrollment
- 144 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Testosterone Cypionate Injection
Primary Outcome Measure
Number of participants with changes in 24-hour average systolic ambulatory blood pressure [ Time Frame: From Baseline to End of Treatment, up to Week 14 (Day 99) ]
Central Contacts
- David J. Sequeira, Ph.D.+1 913 389 7961
- Balraj Sangha+1 510 209 4316
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Alabama Clinical Therapeutics, LLC | Birmingham | Alabama | 35235 | - |
| Hillcrest Medical Research, LLC | DeLand | Florida | 32720 | - |
| Integrity Clinical Research Center, Inc. | Hialeah | Florida | 33015 | - |
| AccuMed Research Associates | Garden City | New York | 11530 | - |
| Aim Trials | Plano | Texas | 75093 | - |
| Alpine Clinical Organization Inc. | Clinton | Utah | 84015 | - |
Find similar trials in Birmingham, AL
Related Studies
- 52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With HypogonadismPHASE3 · Recruiting · Halozyme Therapeutics · Los Angeles, California
- Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active SurveillancePHASE4 · Not Yet Recruiting · University of Miami · Miami, Florida
- Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen DeficiencyPHASE2 · Recruiting · Seattle Institute for Biomedical and Clinical Research · Augusta, Georgia
- Pain Alleviation With Testosterone in Opioid-Induced HypogonadismPHASE2 · Recruiting · Brigham and Women's Hospital · Boston, Massachusetts